IRIS
GALLO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.707
NA - Nord America 653
EU - Europa 305
SA - Sud America 159
AF - Africa 23
OC - Oceania 4
Totale 5.851
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.962
US - Stati Uniti d'America 621
CN - Cina 396
HK - Hong Kong 189
BR - Brasile 121
IT - Italia 102
VN - Vietnam 91
GB - Regno Unito 55
DE - Germania 34
NL - Olanda 28
IN - India 17
FI - Finlandia 16
CZ - Repubblica Ceca 15
CA - Canada 14
MX - Messico 14
AR - Argentina 13
PL - Polonia 13
ID - Indonesia 12
ZA - Sudafrica 12
UA - Ucraina 10
EC - Ecuador 9
FR - Francia 8
TR - Turchia 7
CL - Cile 6
BD - Bangladesh 5
JP - Giappone 5
UY - Uruguay 5
AT - Austria 4
BY - Bielorussia 4
AU - Australia 3
AZ - Azerbaigian 3
BE - Belgio 3
RU - Federazione Russa 3
SE - Svezia 3
CH - Svizzera 2
ES - Italia 2
ET - Etiopia 2
IQ - Iraq 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
PH - Filippine 2
PY - Paraguay 2
VE - Venezuela 2
AO - Angola 1
BJ - Benin 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
GN - Guinea 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
MD - Moldavia 1
ML - Mali 1
NP - Nepal 1
SA - Arabia Saudita 1
TL - Timor Orientale 1
TW - Taiwan 1
UZ - Uzbekistan 1
VG - Isole Vergini Britanniche 1
YE - Yemen 1
Totale 5.851
Salva come PNG Salva come JPEG
Città #
Singapore 288
Hong Kong 185
Ashburn 180
Hefei 159
Beijing 92
Dallas 72
Shanghai 66
Boardman 61
Rome 57
London 35
Ho Chi Minh City 34
Los Angeles 23
Hanoi 19
Munich 17
São Paulo 17
Amsterdam 16
San Francisco 16
Brno 15
Santa Clara 15
Council Bluffs 14
New York 14
Seattle 12
Turku 12
Warsaw 12
Mexico City 11
Boston 10
Haiphong 8
Pune 8
Toronto 8
Atlanta 6
Brooklyn 6
Da Nang 5
Guangzhou 5
Guayaquil 5
Johannesburg 5
Manchester 5
Rio de Janeiro 5
Tokyo 5
Brasília 4
Chennai 4
Helsinki 4
Montevideo 4
Washington 4
Brownsville 3
Canberra 3
Charlotte 3
Chicago 3
Helena 3
Minsk 3
Montreal 3
Stockholm 3
Thái Nguyên 3
Vienna 3
Arayat 2
Baku 2
Bari 2
Belo Horizonte 2
Buffalo 2
Bình Dương 2
Camden 2
Cape Town 2
Central 2
Curitiba 2
Denver 2
Hải Dương 2
Jackson 2
Kharkiv 2
Kuala Lumpur 2
Liverpool 2
Manaus 2
Messina 2
Nairobi 2
Paris 2
Perugia 2
Poplar 2
Providence 2
Ribeirão Preto 2
Salvador 2
Serra Talhada 2
Sete Lagoas 2
Shenzhen 2
Slough 2
Sokal 2
São Carlos 2
Thái Bình 2
Topeka 2
Wembley 2
Accra 1
Addis Ababa 1
Almere Stad 1
Alto Alegre do Pindaré 1
Alvorada 1
Amman 1
Ankara 1
Araguaína 1
Arapiraca 1
Atibaia 1
Augusta 1
Babahoyo 1
Bamako 1
Totale 1.654
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 213
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 206
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 206
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 203
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 195
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 194
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 192
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 191
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 188
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 183
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 182
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 182
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 178
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 173
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 171
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 169
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 103
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 96
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 96
A challenging alfa-fetoprotein in a cirrhotic patient 96
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 93
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 92
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 90
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 90
ALT levels are associated with metabolic parameters and age in a large real-life population. 89
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 87
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 87
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 76
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 75
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 68
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 66
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 63
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 62
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 58
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 54
Sarcopenia in Chronic Liver Disease: The Emerging Role of Ultrasound in Determining Muscle Mass, Strength and Clinical Outcomes 52
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 50
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 49
Pain and Frailty in Hospitalized Older Adults 49
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 43
What changed in the Italian internal medicine and geriatric wards during the lockdown 40
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 37
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 37
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 36
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 35
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 35
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 34
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 34
Renal impairment and anemia during triple therapy 33
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 33
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 30
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 30
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 30
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 29
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 28
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 28
Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study 27
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 27
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables 27
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study 27
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 26
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 26
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 25
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 25
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 25
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 25
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 23
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 23
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 23
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 22
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 22
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 22
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 22
Steroid-refractory immune related hepatitis may hide viral re-activation 22
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 20
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 19
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 18
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 18
Editorial: Clinical management of older persons with sarcopenia: current status and future directions 16
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 15
Decoding the molecular and genomic landscape of hepatocellular carcinoma: biomarker discovery, classification frameworks, and therapeutic targeting 13
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease 12
Totale 5.909
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202290 0 0 2 0 1 0 2 2 12 0 2 69
2022/202319 0 0 0 0 1 2 5 1 1 3 6 0
2023/2024176 6 14 4 23 13 78 2 6 3 6 5 16
2024/20254.457 38 16 66 12 129 98 77 14 176 263 1.749 1.819
2025/20261.167 243 156 192 300 135 141 0 0 0 0 0 0
Totale 5.909